VOLIBRIS Film-coated tablet Ref.[6154] Active ingredients: Ambrisentan

Source: European Medicines Agency (EU)  Revision Year: 2018  Publisher: GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Product name and form

Volibris 5 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet (tablet).

Pale-pink, square, convex, film-coated tablet with “GS” debossed on one side and “K2C” on the other side.

Qualitative and quantitative composition

Each tablet contains 5 mg of ambrisentan.

Excipient(s) with known effect: Each tablet contains approximately 95 mg of lactose (as monohydrate), approximately 0.25 mg of lecithin (soya) (E322) and approximately 0.11 mg of Allura red AC Aluminium Lake (E129).

For the full list of excipients, see section 6.1.

Active Ingredient

Ambrisentan is an orally active, propanoic acid-class, ERA selective for the endothelin A (ETA) receptor. Endothelin plays a significant role in the pathophysiology of PAH.
List of Excipients

Tablet core:

Lactose monohydrate
Microcrystalline cellulose
Croscarmellose sodium
Magnesium stearate

Film coat:

Polyvinyl alcohol (partially hydrolysed)
Talc (E553b)
Titanium dioxide (E171)
Macrogol 3350
Lecithin (soya) (E322)
Allura red AC Aluminium Lake (E129)

Pack sizes and marketing

PVC/PVDC/aluminium foil blisters.

Pack sizes with unit dose blisters of 10x1 or 30x1 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Marketing authorization dates and numbers

EU/1/08/451/001
EU/1/08/451/002

Date of first authorisation: 21 April 2008
Date of latest renewal: 24 April 2013

Drugs

Drug Countries
VOLIBRIS Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈